Conclusion
There is a lack of evidence to draw conclusions as to whether CCBs are
the most effective anti-hypertensive agent for Black patients with HDP.
Although we do not advocate for randomised control trials to investigate
HDP in specific ethnic groups, this review emphasises the need for
routine reporting of race and ethnicity demographics, as well as
stratification of clinical outcomes by ethnicity in trials investigating
HDP.